Fiercebiotech
Published November 17, 2026
Big Pharma-backed Seawolf surfaces with $100M to hand, $1.2B Sanofi DNA med pact
Read the full story at Fiercebiotech
Gene therapy biotech Seawolf has emerged from the deep with $100 ... Helus' chemically modified psychedelic hits key goals in phase 3 depression trial.
Surfaced by this Google Alert
- Psychedelic biotech